Dr. Arvind R. Yertha, MD

Dr. Yertha practices at Oklahoma Center for Orthopaedic Multi-Specialty Surgery in Oklahoma City, Oklahoma, part of Oklahoma Center for Orthopaedic & Multi-Specialty Surgery.

Dr. Yertha's NPI, 1720178197, was assigned on October 13, 2006. Dr. Yertha holds Louisiana license 026339.

Dr. Yertha's primary practice is Oklahoma Center for Orthopaedic Multi-Specialty Surgery, at 8100 South Walker Bldg C, Oklahoma City, OK 73139 in Oklahoma County. The practice phone is (405) 602-6500.

Dr. Yertha's primary practice is Oklahoma Center for Orthopaedic Multi-Specialty Surgery in Oklahoma City, Oklahoma, part of Oklahoma Center for Orthopaedic & Multi-Specialty Surgery. Dr. Yertha is also affiliated with North Oaks Medical Center. The medical group on file is North Oaks Medical Center. Dmand AI also links Dr. Yertha to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yertha practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Yertha's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Yertha is licensed in Louisiana.

CMS data shows 1,763 Medicare services from Dr. Yertha across 12 procedure codes in 2024, for 474 Medicare patients. Medicare paid $136,768 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 474 Medicare patients who saw Dr. Yertha in 2024. The largest group is 65 to 74, with 192 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yertha's median patient age at 70, with 53% women.

In 2024, Dr. Yertha wrote 2,329 Medicare Part D claims for 366 patients. CMS names the drug for 2,187 of them, across 35 drugs with 11 or more claims each, at $1,091,285 in total drug cost. In 2023, CMS named 1,391 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Yertha for performance year 2024, reported as part of a group. Dr. Yertha accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 354 general payments to Dr. Yertha from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 87% of the total. GlaxoSmithKline, LLC. paid the most, $2,632.